Trial: 202007016

Phase Ib/II study to evaluate safety and tolerability of cabiralizumab in combination with nivolumab and neoadjuvant chemotherapy in patients with localized triple-negative breast cancer

Phase

I/II

Principal Investigator

Opyrchal, Mateusz

Disease Site

Breast

Learn more about this study at: clinicaltrials.gov